111 related articles for article (PubMed ID: 16315248)
1. The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy.
Zlobec I; Vuong T; Compton CC
Cancer; 2006 Jan; 106(2):284-6. PubMed ID: 16315248
[TBL] [Abstract][Full Text] [Related]
2. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.
Zlobec I; Steele R; Nigam N; Compton CC
Clin Cancer Res; 2005 Aug; 11(15):5440-3. PubMed ID: 16061859
[TBL] [Abstract][Full Text] [Related]
3. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
Zlobec I; Steele R; Compton CC
Cancer; 2005 Dec; 104(11):2517-21. PubMed ID: 16222693
[TBL] [Abstract][Full Text] [Related]
4. [Smac as a predictive marker of tumor response to preoperative radiotherapy in rectal cancer].
Pan ZZ; Lin JZ; Wan DS
Ai Zheng; 2008 Feb; 27(2):178-82. PubMed ID: 18279617
[TBL] [Abstract][Full Text] [Related]
5. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
Zlobec I; Vuong T; Compton CC; Lugli A; Michel RP; Hayashi S; Jass JR
Br J Cancer; 2008 Jan; 98(2):450-6. PubMed ID: 18182986
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
8. Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
Leo C; Horn LC; Rauscher C; Hentschel B; Richter CE; Schütz A; Leo CP; Höckel M
Clin Cancer Res; 2007 Feb; 13(4):1149-53. PubMed ID: 17317823
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
10. Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors.
Spindler KL; Nielsen JN; Lindebjerg J; Jakobsen A
Dis Colon Rectum; 2007 Sep; 50(9):1363-9. PubMed ID: 17661145
[TBL] [Abstract][Full Text] [Related]
11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
12. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.
de Heer P; Gosens MJ; de Bruin EC; Dekker-Ensink NG; Putter H; Marijnen CA; van den Brule AJ; van Krieken JH; Rutten HJ; Kuppen PJ; van de Velde CJ;
Clin Cancer Res; 2007 May; 13(10):2955-60. PubMed ID: 17504996
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors.
de Bruin EC; van de Velde CJ; van de Pas S; Nagtegaal ID; van Krieken JH; Gosens MJ; Peltenburg LT; Medema JP; Marijnen CA
Clin Cancer Res; 2006 Nov; 12(21):6432-6. PubMed ID: 17085656
[TBL] [Abstract][Full Text] [Related]
16. Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.
Zhou JN; Wang DZ; Huang XE; Xu FP; Shang JQ; Gu RM
Isr Med Assoc J; 2006 Oct; 8(10):675-8. PubMed ID: 17125111
[TBL] [Abstract][Full Text] [Related]
17. Is p53 and heat shock protein 70 expression a useful parameter for preoperative hyperthermoradiation therapy in advanced rectal carcinoma.
Takeuchi K; Nakajima M; Miyazaki T; Ide M; Asao T; Fujita K; Kuwano H
Hepatogastroenterology; 2007 Mar; 54(74):367-72. PubMed ID: 17523276
[TBL] [Abstract][Full Text] [Related]
18. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
20. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
